Form D · Biotechnology

Zeta Biolongevity, Inc.

Austin, TX · CIK 0001735987

Offering snapshot reported Dec 10, 2018 · SEC filing

Reported sold
$995K
Offering amount: $2M
Investors reported
16
Form D · investor count
Minimum accepted
$5K
Reported outside-investor minimum
First sale
Mar 10, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$498K$995KMar 29, 2018: $50,000.00Mar 29, 2018Dec 10, 2018: $995,000.00Dec 10, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$50,000 → $995,000
  • Reported investors1 → 16
  • Minimum accepted$50,000 → $5,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 10, 2018Amendment$995,000$945,000vs Mar 29, 201816SEC filing
Mar 29, 2018Initial$50,000No comparison1SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-308925

Source: Form D, filed Dec 10, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Tim Connelly Director, Executive
Randy Thompson Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
4605 Gray Fox Drive
Austin, TX, 78759